| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 525,304 | 460,258 | 449,511 | 575,442 | | Cost of Revenue | 420,937 | 381,484 | 381,487 | 490,158 | | | Gross Profit | 104,367 | 78,774 | 68,024 | 85,284 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 119,296 | 83,752 | 87,454 | 97,951 | | Non Recurring | (26,151) | 41,719 | 18,933 | 594,712 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,222 | (46,697) | (38,363) | (607,379) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 327 | (5,510) | 12,883 | 3,548 | | Earnings Before Interest And Taxes | 11,549 | (52,207) | (25,480) | (603,831) | | Interest Expense | 2,626 | 2,787 | 2,864 | 6,729 | | Income Before Tax | 8,923 | (54,994) | (28,344) | (610,560) | | Income Tax Expense | 6,414 | 3,715 | 710 | 36,215 | | Minority Interest | (186) | (229) |
-
| 173 | | | | Net Income From Continuing Ops | 2,738 | (58,938) | (29,054) | (646,602) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (5,690) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,323 | (58,938) | (29,054) | (652,292) | | Preferred Stock And Other Adjustments |
-
| 73 | (73) |
-
| | | Net Income Applicable To Common Shares | $2,323 | ($58,865) | ($29,127) | ($652,292) |
|
0.51% Nasdaq 
Income Statement
